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HYBRID RNA VIRUS Plant Virus Infections and Comparative Diagnosis, E. 
Kurstak (ed.), at 541-564; P. J. G. Butler (1984) "The 
This application is a continuation of application Ser. No. Chrrent Picture of the Structure and Assembly of Tobacco 
081158,082, filed N ~ ~ .  23, 1993, now ~ b ~ d ~ ~ ~ d ,  which is Mosaic Virus," J. Gen. Virol. 65253-279; D. L. Beck, et al. 
a continuation of application Ser. NO. 071978,313, filed NOV. 5 (19851, "Synthesis of Full-length cDNA Clones of TMV," 
17, 1992, now Abandoned, which is a continuation of P h ~ t o ~ a t h o l o g ~ ,  7.511334 (Abstract); and W. 0 .  Dawson, et 
application Ser. No. 071518,242, filed May 4, 1990, now al (Iga6) of the Genome of 
Abandoned, which is a continuation of application Ser. No. Tobacco Mosaic Virus and Production of Infectious Tran- 
071012,253, filcd Feb. 9, 1987, now Abandoned. scripts," Proc. Natl. Acad. Sci. U.S.A. 83:1832-1836. 
lo The coat protein of such rod-shaped virions is encoded by 
an RNA gene. An assembly origin sequence is also neces- 
FIELD OF INVENTION sary to initiate packaging. A cDNA clone containing the 
This invention relates to the use of RNA plant viruses for assembly origin of TMV Cowpea Strain (Cc) and coat protein gene has been isolated by T. Meshi, et al. (1981) genetic engineering to transform plant cells and systemically 
~~Nucleotide Sequence of a Cloned cDNA Copy of TMV 
infect plants, and in particular relates to packaging viral 15 (Cowpea Strain) RNA, Including the Assembly Origin, the 
sequences in heterologous coat proteins. Coat Protein Cistron, and the 3' Non-Coding Region," Mol. 
Gen. Genet. 184:2&25. In this particular %UV strain, the 
BACKGROUND OF THE INVENTION assembly origin sequences are within the coat protein gene; 
however, in other strains, the assembly origin and coat 
It has been recognized that RNA viruses am useful in the 20 protein genes are separate. 
genetic engineering of plants, particularly (*) strand mes- 
 he coat proteins of rod-shaped virions are assembled in 
senger sense RNA viruses. See, e.g., U.S. Patent application a helical array, encapsidate the RNA rod-shaped viral 
Scr. No. 580,445 and the continuation-in-part application particle with RNA wound helically within the interior of the 
thereof filed simultaneously herewith, and Ser. No. 709,181, extendable particle. Thus, in order to increase the size range 
incorporated herein by reference. 25 of genetically engineered RNA vital sequences, it is an 
A problem with prior methods involving the use of RNA object of this invention to provide a recombinant RNA 
viruses for genetic engineering of plants, however, has been sequence encapsidated in a rod-shaped coat. 
the fact that many plant viruses providing suitable sites for In general, it would be desirable to package viral 
the insertion of RNA copies of foreign genes are encapsi- sequences in any heterologous coat protein capsid, for 
dated in their naturally infective state in spherical or icosa- 30 example when the desired host has established immunities 
hedral capsids which impose geometric constraints on the against the natural coat protein of the viral sequence with 
amount of genetic material which can be carried by these which infection is desired. However, prior to this invention, 
viruses. no hybrid viruses combining functions (e.g., host specificity, 
Examples of such useful viruses are the tripartite infectivity, and the like) derived from more than one RNA 
of Tricomaviridae, such as brome mosaic virus (BMV), and 35 virus had been ~onstructed. 
cowpea chlorotic mottle virus (CCMV), which are packaged A viable recombinant was constructed at the cDNA level 
in icosahedral capsids. The BMV RNAl segment has been between poliovirus types 1 and 3 which are 70% homolo- 
cxtcnsively studied as a carrier for heterologous RNA; gous in RNA sequence (G. Stanway et al. (1986), "Con- 
however, observation of the structure of functional elements struction of poliovirus intertypic recombinants by use of 
of this RNA segment indicate that the 3.2-3.3 kb size of the 40 cDNA," J. Virol. 57: 1187. This recombinant carried the 0.74 
natural BMV RNAl is probably near the maximum size kb 5' untranslated sequence and first 11 polyprotein codons 
which can be carried by the icosahedral BMV coat. from type 3, with the remainder of the sequence from type 
BMV RNA3 is around 2.1 kb in size, so only around 1 kb 1. A second recombinant reported involved insertion of a 
at most of foreign sequence could be added to a packagable 45 portion of the VP1 capsid protein gene from type 3 into a 
RNA3 derivative without deletion of a of the natural type 1 Context, but this was n0n-viable, indicating problems 
BMV RNA3 sequence. Although in the case of BMV RNA3, in combining non-homologous functional regions. 
which has been extensively studied, identification of An additional example of recombination between diver- 
sequences which are not required in cis for replication and gent Picomavirus genomes was the construction of a recom- 
gene expression opens the possibility of constructing vari- 50 bination between poliovirus type 1 and coxsackie B3 virus 
ants with such deletions, it is highly desirable for increased (B. L. Sernler et al. (1986), "A chimeric plasmid from cDNA 
freedom and flexibility in making more sophisticated virus clones of poliovirus and coxsackie virus that is temperature- 
derivatives to be able to add heterologous RNA sequences sensitive," Proc. Natl. Acad. Sci. USA 83:1777). In this ease 
without being required to delete an equal amount of the a 0.4 kb segment of the coxsackie B3 5' noncoding region 
original viral RNA. The possibility also exists for BMV and 55 was inserted in a poliovirus context, replacing a segment 
some other isometric viruses that lower as well as upper with which it had 70% homology. The resulting recombinant 
RNA size limits exist for viral RNA packaging (Ahlquist et virus was viable but showed a temperature-sensitive repli- 
al. (1984) J. Mol. Biol. 172:369-383). cation phenotype. 
It would thus be desirable to encapsidate recombinant In none of these reported attempts to produce recombinant 
RNA viral sequences into a coat protein able to freely 60 viruses was a viable hybrid virus produced in which a 
package pieces of RNA without upper or lower size con- substitute segment had less than 70% homology with the 
straints. segment it replaced, and in no case were separate functions 
In contrast to the icosahedral viruses, a large class of plant from two or more different viruses successfully recombined. 
viruses have elongated virions with the shape of rigid or Nor has the artificial construction of a hybrid RNA plant 
flexuous reds. The tobacco mosaic virus is an example 65 virus from two distinct viral types been reported. 
which has been extensively studied. See, e.g., M. H. V. Van Unencapsidated derivatives of rod-shaped viruses have 
Regenmortel (1981) "Tobamoviruses," in Handbook of been recently used as vectors to carry a foreign gene in 
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recombinant RNA (Takamatsu, N. et al., "TMV-RNA medi- derived from or corresponding to reverse-transcribed viral or 
ated foreign gene expression in tobacco plants," In press), transposon RNA, viroids and virus satellites. 
and recombinant RNA sequences have been encapsidated in Such viral sequences must as a minimum have the func- 
a rod-shaped coat in vitro (Sleat, D. E. et al., "Packaging of tions of replicability in the host and ability to infect the host. 
Recombinant RNA Molecules into Pscudovirus Particles 5 Determinants of such functions may be required in cis or in 
Directed by the Origin-of-Assembly Scquence from other cases may be suppliable in trans. An example of a 
Tobacco Mosaic Virus RNA," In press). However, the in replication requirement satisfiable in trans is the need for the 
viva packaging of a recombinant viral RNA in a capsid presence of the proteins encoded by BMV RNA's 1 and 2 in 
foreign to the infective viral sequences has not been previ- order to allow BMV RNA3 to replicate in a host. 1n contrast, 
ously reported. 10 certain replication signals must be present in cis (i.e. directly 
linked to RNA3 derivatives) to allow replication of RNA3 
derivatives by the machinery induced in the infected cell by 
SUMMARY OF THE INVENTION RNA's 1 and 2. 
RNA viruses make useful vectors for genetic engineering It is also desirable that such original viral sequences have 
of plants and other higher organisms to confer useful traits 15 suitable sites for the addition of foreign or heterologous 
such as herbicide, disease and pest resistance, however genes. The terms ''foreign" and "heterologous" in reference 
exiting systems are not as flexible as is desired. Encapsida- to genes and sequences mean genes or sequences not 
tion of an RNA viral sequence appears to be required for its encoded in the original virus in nature. Such foreign genes 
significant and reliable spread through the host system. or sequences may be inserted in any location not giving rise 
Uncoated RNA viruses, for example, can infect single cells 20 to interference with the necessary functions of the original 
and protoplasts, and in the case of some single component viral sequences, i.e., the ability to replicate and infect a host. 
FWA viruses, can spread erratically to sites distant from the In reference to expression in a host, a "heterologous" gene 
original inoculation site. However, efficient transmission is one which is not naturally present in the location in the 
throughout the plant from a single site of infection or host in which it has been placed. 
transfection, particularly for the many multicomponent plant 25 Similarly, it is desirable that the placement of the heter- 
RNA viruses, requires encapsidation in a viral coat. This ologous coat protein genes and assembly origins not inter- 
invention provides methods for creating hybrid viruses in fere with such necessary functions of the original viral 
which infective viral sequences are packaged in heterolo- sequences. 
gous coat protein capsids. Encapsidated hybrid virions are Coat protein sequences from flexible or rigid rod-shaped 
also provided, as well as hybrid viral RNA sequences 30 RNA viruses are especially useful in this invention, in 
capable of encapsidation in vitro or in vivo. combination with an assembly origin capable of regulating 
As used herein, the term "hybrid RNA virus" refers to the coat protein sequences. Generally, as is recognized in the 
recombinant viruses in which functional sequences from two art, assembly origins are specific to their coat protein genes, 
or more different viruses are combined to form a viable so it is preferred that the coat protein genes rand assembly 
organism. Specifically, the hybrid RNA viruses of this 35 origins are derived from the same organism. Coat protein 
invention are RNA sequences comprising infectious viral genes containing their assembly origins within the gene, e.g. 
sequences derived from one RNA virus, and an origin of TMV Cowpea (Cc) strain genes, are particularly preferred. 
assembly and coat protein gene derived from another virus 
~ h ,  foreign RNA sequences to the original viral 
(or other viruses). The term "hybrid RNA virion" refers to 40 RNA may be or encode functional R N A ' ~ ,  and the host 
the encapsidated form of such viruses. organism may be transfected and transformed genotypically 
Many useful RNA viruses are encapsidated in icosahedral or phenotypically. A functional FWA is one which provides 
coats which limits thc size of genes that can be added. A any function which is appropriate and known to be provided 
method of encapsidating RNA vital sequences in rod-shaped by an RNA segment. Such functions include, but are not 
coat protein capsids is therefore provided. These coat protein 45 limited to, coding functions in which the RNA acts as a 
capsids are expansible to accommodate large-sized RNA messenger RNA encoding a sequence which, translated by 
fragments up to at least the 6.4 kb size of the tobacco mosaic the host cell, results in synthesis of a peptide or protein 
virus. RNA fragments as large as desired may be encapsi- having useful or desired properties. Such proteins are termed 
dated in rod-shaped particles so long as the particles are not "functional proteins" herein. The RNA segment may also be 
so large as to be substantially broken by normal physical 50 structural, as for example in ribosomal RNA; it may be 
manipulations. regulatory, as for example with small nuclear RNA's or 
A recombinant viral RNA sequence is provided in which anti-sense RNA, or it may be catalytic. Anti-sense RNA is 
original viral sequences from a virus normally encapsidated useful to inhibit the function of complementary RNA in the 
in one type of coat protein are encapsidated in a different target cell. 
type. Preferably an infectious virus normally encapsidated in 55 As will be appreciated by those skilled in the art, if the 
an icosahedral capsid or otherwise not normally encapsi- inserted RNA sequence is in the form of messenger-sense 
dated in a rod-shaped capsid are combined with genes and RNA comprising genes to be directly translated by the 
assembly origins for the production of a rod-shaped capsid, transformed cell, the genes must be free of intervening, 
thus enabling encapsidation of the original viral sequences non-translated sequences, such as introns. On the other 
in a rod-shaped capsid. The original viral sequences prefer- 60 hand, inserted genes need not be naturally occurring genes, 
ably are modified to contain desirable foreign genes. but may be modified, composites of more than one coding 
An original viral RNA sequence suitable for combining Segments, or encode more than one protein. The RNA may 
with heterologous coat protein genes and assembly origins is also be modified by combining insertions and deletions in 
a sequence derived from or corresponding to that of an RNA order to control the total length or other properties of the 
virus. Examples of such viruses are plus strand viruses such 65 modified RNA molecule. 
as BMV, Tricornaviridae in general, and many others, as The inserted foreign RNA sequences may be non-viral or 
known to the art. Further useful virus sequences are those viral in origin, and may correspond either to RNA or DNA 
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in nature. They may be prokaryotic or eukaryotic in origin, be systemically infected, but is preferably systemically 
so long as they are in a form which can be directly translated infected. 
by the translation machinery of the recipient cell or other- 
~ ~ ~ h ~ d ~  for initiating infection of the host organism are 
wise recognized and utilized for their functional, structural well known to the art, and any suitable method may be used, 
or regulatory functions. 5 A preferred method for the infection of plants is to contact 
As discussod above, "expression" of the foreign RNA the wounded plant with a solution containing the virus or 
sequences may involve the production of functional RNA's viral W A  so as to cause the virus to replicate in, or infect 
or functional proteins. This expression may be at any useful the plant, level, and as will be appreciated by those skilled in the art, 
suitable regulatory elements may be necessary depending on lo BRIEF DESCRIPTION OF THE FIGURE 
the product desired and the host used. Providing such 
regulatory elements is a matter of ordinary skill in the art. FIG. 1 shows a schematic diagram of the viral cDNA 
The natural TMV RNA is about 6.4 kb in length. Rod- regi0ns plasmids P~~~~~ BMV m A 3 9  
shaped capsids of this invention, however, may be as long or P ~ ~ ~ S ~  having the coat protein start codon modified from 
as short as required. As the maximum size the icosahedral 1s ATG to AAG, pB3ITMV having the coat protein and 
capsid of BMV is believed capable of encapsidating is about substituted for the BMV RNA3 pro- 
3.2 kb, it can be seen that the use of a rod-shaped coat tein, and ~~~~~5 Ihe TMV protein and 
considerably expands the size range of engineered viral assembly origin, showing construction of PB~ITMV. 
sequences that can be made competent by encapsidation for 
systemic spread in hosts previously accessible only to icosa- 20 DETAILED DESCIUPTION OF THE 
hedrally encapsidated viruses. PREFERRED EMBODIMENTS 
As discussed below, insertion of foreign RNA sequences In a preferred embodiment of this invention, an RNA 
is preferably done through reverse transcription of all segment of an icosahedral virus, preferably a tripartite virus, 
sequences involved into corresponding cDNA, or in the case and more preferably BMV, is packaged in a cylindrical 
of foreign sequences originally derived from DNA, original 25 capsid, preferably of TMV, and more preferably of TMV 
DNA sequences can be used. Any suitable vector may be Cowpea strain (Cc) coat protein. Preferably, the packaged 
used to provide a basis for carrying out such genetic engi- sequence is also modified to contain a heterologous gene. 
neering, all as will be evident to those skilled in the art. The genome of BMV is divided among messenger sense 
Preferred plasmids are discussed in the Example hereof. R N A ' ~  1 , 2  and 3 of 3.2,2.9 and 2.1 kb respectively, CDNA 
Techniques for constructing desired DNA sequences or 30 copies of these W A ' s  have been cloned into the universal 
combinations of DNA fragments are well known to the art, transcription vector pPM1. The clones, containing RNA's 1, 
using appropriate restriction enzymes, ligation techniques 2 and 3, respectively are designated pBlPM18, pB2PM25 
and oligonucleotide-directed alterations available for Con- and pB3pM1, In order for cells to be infected with BMV 
strutting combinations of fragments containing the desired m A 3 ,  the proteins encoded by BMV RNA's 1 and 2 must 
f~nctions. Techniques for testing Such C O ~ S ~ ~ U C ~ ~ O ~ S  to 35 be present. In the preferred embodiment these three BMV 
assure their operativeness are also well known and will not RNA's are separately encapsidated in the rod-shaped virus 
be discussed in detail herein. coat protein. 
Similarly, any art-known bacterial host for vectors con- In the preferred embodiment, BMV RNA's 1, 2 and 3 
taining the DNA sequences of this invention may be utilized each contain an appropriate assembly origin, but only the 
in conducting the genetic engineering andlor obtaining RNA 40 BMV RNA3 sequence contains an added coat protein 
transcripts of the DNA sequences in viva. RNA transcripts although any of the sequences may be modified to contain 
may also be produced in vitro, for example by the methods additional RNA sequences such as sequences encoding 
of U.S. Ser. NO. 580,445 and the ~ ~ n t i n ~ a t i ~ n - i n - p a r t  a pli- functional protein or functional W A ' s .  Methods of modi- 
cation thereof. 4j  fying DNA sequences to insert heterologous or foreign 
Any plant may be infected with an RNA sequence of this sequences are well known to the art. Generally the viral 
invention, as will be evident to those skilled in the art, by RNA sequence is converted to a full-length cDNA transcript 
providing appropriate host specificity and replication func- and cloned into a vector, then modified by inserting a foreign 
tions. With appropriate constructions, other eukaryotic DNA segment in a region able to tolerate such insertion 
organisms may also be infected, as may single cells and without disrupting RNAreplication or disturbing infectivity. 
tissue cultures. This invention is not limited to any given It is necessary that the viral RNAbeing packaged have the 
class of host or type of RNA virus. The general utility of gene for its own coat protein deleted or inactivated so as to 
providing a heterologous protective Coat Or encapsidation, avoid interference with the added coat protein gene. Means 
especially one allowing size expansion to a viral sequence, for inactivating viral coat protein genes are well known to 
will be recognized by those skilled in the art as an improve- 55 the art. See, e.g. Ahlquist et al. (198 1) "Complete Nucleotide 
ment in any process involving the use of viruses which can Sequence of Brome ~ o s a i c  virus RNA3," J. ~ 0 1 .  Biol, 
be improved by added RNA sequences. 153:23-38. A preferred method for inactivating the gene is 
The term "systemic infection" means infection spread simply by deletion of the gene or substantial portions 
through the system of the host organism to involve more thereof. Other methods include point mutation or insertional 
than the cells at the site of original inoculation. The entire 60 inactivation. 
host organism need not be infected; single organs or even In order to ensure translational fidelity of the heterologous 
Parts of organs are sufficient, depending on the PuTose of coat protein gene, it may also be necessary to modify the the 
the infection. translation initiation ATG codon for the original coat protein 
The term "transfected" as applied to the host organism if this is not deleted, and this may be accomplished by means 
means incorporation of the viral sequences of this invention 65 known to the art, such as oligonucleotide-directed substitu- 
into the cells of the organism in such a way as to be tion. If the coat protein sequence to be added has its own 
replicated therein. To be transfected, the organism need not translational start codon, deletion or inactivation of the start 
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codon for the original protein is necessary; alternatively, be identified and mapped if the entire original virus provid- 
however, it may be retained and used to initiate translation ing the necessary genes is used. 
of the addcd coat protein sequence, provided that any amino Suitable genes which may be inserted into the original 
acid sequcnce changes introduced thereby do not interfere viral segment for expression in the host plant include the 
with RNA packaging and capsid formation. 5 CAT (chloramphenicol transferase) gene, pest resistance 
Many RNA viruses producing rod-shaped virion ~aflicles genes, e.g. Bacillus thuringiensis insecticidal protein genes, 
are known to the art (See, e4.7 Plant Virology (2nd ed.1, R. pathogen resistance, herbicide tolerance or resistance, modi- 
E. F.  att thews (1981) Academic Press, New York, and "4th fied growth habit and new metabolic pathway genes, and 
Report of the International Committee on tax om on^ of genes for production of commercially useful peptides or 
Viruses", (1982) Intervirology 17:1-199). Useful coat Pro- lo pharmaceuticals in plants or other host organism. In general, 
tein and origin of assembly sequences may be isolated and any heterologous gene whose expression product is func- 
reverse transcribed from such viruses by means known to tional within the plant cell can be inserted into the viral 
the art without undue experimentation. Preferred sequences expression system described herein. 
are TMV sequences, and preferred are 'Oat protein Plants may be transfected both under field and greenhouse 
genes incorporating their own assembly origins such as the 15 conditions. The modifications can be applied at any time 
'Oat protein gene of TMV Cowpea ('c) strain. 'lasmid during the growth cycle, depending on the need for the trait. 
P~~~~~ of et contains For example, resistance to a pest could be conferred only if 
ing to such sequences, and was obtained Meshi et al. the crop were at risk for the pest, and at the time when the 
for the work discussed here. The wide availability of this crop was most likely to be affected by the pest. Other traits 
strain and the fact that the sequences of the coat protein gene 20 can be used to enhance secondary properties, for example to 
and of have been published CMeshi et increase the content of post-harvest forage. Any 
supra) makes thc reconstruction of this plasmid andlor said plant variety susceptible to infection by an RNA virus can be 
sequences a matter of ordinary skill in the art. phenotypically transformed. The choice of virus and the 
Through standard cloning techniques, the coat protein details of modification will be matters of choice depending 
gene and assembly origin sequences of rod-shaped virions 25 on parameters known and understood by those of ordinary 
are ligatcd into the viral sequences to be packaged, prefer- in the ad. 
ably at the site where the original coat protein gene for the Other uses for cells and organisms phenotypically or 
virus was removed, but in any event at a site which does not genotypically modified by means of a modified RNA 
interfere with the ability of the virus to replicate and infect 3o derived from an RNA virus will be readily apparent to those 
its hosts. skilled in the art, given a wide range of RNA viruses to 
'hnslational expression of the inserted new coat protein modify and a wide range of susceptible host cell types. Other 
gene may be provided by known means. In the example, the uses for transfected animal cells, bacterial cells and the like 
TMV coat protein gene was inserted immediately down- can be readily envisioned. For example, animal cells sus- 
stream of the initiation site for subgenomic BMV RNA4, ceptible to infection by the alphaviruses, which share 
leading to BMV-directed synthesis of a subgenomic mRNA 35 homologous nonstructural proteins and many features of 
for TMV coat protein. The TMV gene is thus said to be viral replication with BMV, may be infected in cell culture 
placed downstream of a "subgenomic promoter." with a modified alphavirus carrying a desired gene and 
The foreign genes for which expression in the host plant thereby caused to express large quantities of a desired 
is desired may be inserted at any convenient location in the 40 protein within a short time. The encapsidated RNA viruses 
genome of the original virus which does not interfere with of this invention are especially useful when it is necessary to 
the ability of the virus to replicate and infect the host. subject the virus to harsh conditions, due either to environ- 
Preferably the foreign genes are inserted immediately mental conditions or host defenses, which would inactivate 
upstream from the coat protein and its subgenomic pro- the uncoated virus. 
meter. A COPY of the subgenomic Promoter normally regu- 45 The method of making and using genetically engineered 
lating Coat protein in the original virus may also be placed is described herein with particular reference to BMV 
Upstream of such foreign genes to allow for their transitional R N A ' ~ ,  but the ordinarily skilled artisan will be able to 
expression. apply the principles described, using known techniques, to 
RNA transcripts are prepared, in vivo, such as in bacterial other viral RNA's. 
hosts, or in vitro, all as known to the art, and used to 50 
inoculate an appropriate plant host or plant tissue. Thc RNA 
can be used in encapsidated form or in solution, since EXAMPLE 
encapsidation will occur within the host organism. The following discussion describes the insertion of a 
As will be understood by those skilled in the art, a given TMV coat protein gene and assembly origin in BMV RNA3, 
virus may require special conditions for optimal infectivity 55 expression of the inserted gene, and in viva packaging of the 
and replication, including the presence of genes acting in cis hybrid RN.4 in rod-shaped particles. 
or in trans, all of which should be present when infecting the Plasmid pB3TP7 contains the full-length cDNA copy of 
plant or plant tissue. For example, for infectivity of BMV BMV RNA3 from plasmid pB3PMI fused 3' to a promoter 
RNA3, the presence of BMV RNAl and 2 is necessary. for bacteriophage 'I7 RNA polymerase, allowing biologi- 
Moreover, infection by a virus having the necessary host- 60 cally active RNA3 transcripts to be produced in vitro. The 
specificity genes for a given host can in some circumstances initiating ATG codon of the BMV coat protein in this 
allow infection of the host by a second virus which does not plasmid was modified by oligonucleotide-directed substitu- 
normally affect that host, e.g. mixed TMV and BMV viruses tion (Zoller and Smith (1982) Nucl. Acids. Res. 
will infect both barley and tobacco even though BMV alone 106487-6500; Kunkel (1985) Proc. Natl. Acad. Sci. 
does not infect tobacco and TMV alone does not infect 65 82:488-492) to an AAG codon to generate plasmid pB3RS2. 
barley (Hamilton and Nichols (1977) Phytopathology, FIG. 1 shows a schematic representation of the viral cDNA 
67:484-489). It is not necessary that all the required genes portions of these plasmids. 
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Plasmid pCc8C5 contains a partial cDNA copy of the prising a first RNA sequence derived from a first virus and 
RNA of the cowpea (Cc) strain of tobacco mosaic virus a second RNA sequence from a second virus have a mor- 
(Meshi et al., supra). Using standard methods (Maniatis et phologically-different type of coat protein, said second RNA 
al. (1982) Molecular Cloning, CSH Laboratory), the sequence comprising an origin of assembly and encoding a 
approximately 0.5 kb SalI-XbaI fragment of PB3RS2 inte- 5 coat protein heterologous to said first virus, wherein the coat 
rior to the BMV coat gene was then replaced by the protein gene of said first virus is deleted from or inactivated 
approximately 0.6 kb MboII-Xbal fragment of PCc8C5, in said first RNA sequence and said second RNA sequence 
which contains the entire coat protein gene of TMV Cc, is substituted therefor to produce a hybrid RNA molecule 
including sequences believed to represent the encapsidation capable of expressing the coat protein gene of said second 
origin of the RNA (Meshi et al., supra). The SalI and MboII lo virus, and wherein said hybrid molecule is constructed in 
restriction fragment ends were both repaired to blunt ends vitro from said first virus RNA sequence and said second 
with T4 DNA polymerase prior to ligation. The resulting RNA sequence, or wherein said hybrid molecule is 
plasmid will be referred to as pB3/TMV. descended from a nucleic acid molecule constructed in vitro 
Transcripts from EcoRI-linearized pB3/TMV, including using recombinant DNA technology. 
the complete BMV RNA3 TMV sequences contained in 15 2. A molecule of claim 1 which is capable of encapsida- 
that plasmid were inoculated onto barley protoplasts along tion in viva. 
with infectious transcripts of BMV RNAl and RNA2 cDNA 3. A molecule of claim 1 further comprising a sequence 
clones (French et al. (1986) Science 231:1294-1297.) The heterologous to said first virus which encodes a functional 
pB3/TMV RNA's were replicated in such infections and protein. 
gave rise to a subgenemic RNA of the size expected for a 20 4. A molec~le of claim 1 wherein Said first virus is an 
mRNA initiated at the normal BMV RNA3 subgenomic i ~ ~ ~ a l ~ e d r a l  virus. 
initiation site and containing all sequences between that 5. A molecule of claim 1 wherein said first virus is a 
point and the 3' end of the BMV RNA sequence, including rod-shaped virus. 
the TMV Cc sequence insertion. 6 .  A molecule of claim 1 having a length greater than 
RNA samples were derived from protoplasts inoculated 25 about 3.2 kb. 
with transcripts of wild type cDNA copies of BMV RNA,s 7. A molecule of claim 1 wherein the origin of assembly 
1 and 2 and either no additional transcript (-) or transcripts and 'Oat protein gene are derived from TMV. 
of either wild type BMV RNA3 cDNA or pB3mV. Flue- 8. A molecule of claim 1 wherein said RNA sequence 
rographs of 3Huridine labelled RNA's separated on a 1% said first virus is BMV IZNA3' 
(W/V) agmse  gel after extraction from protoplast 30 9. A molecule of claim 1 wherein said first virus is a plant 
variously inoculated and incubated for 20 hours in light at 24 
degrees C. showed the presence of all these RNA's. 10. A hybrid RNA molecule capable of infection of and 
replication in a host cell, said hybrid RNA molecule com- 
'ysates of P ~ ~ ~ ~ P ~ ~ ~ ~ ~  infected prising an RNA segment derived from a first non-rod-shaped 
with transcripts of BMV RNA1l RNA and pB3mV were 35 virus and an RNA sequence from a second rod-shaped virus, 
serologicall~-s~ecific (K. said second virus RNA sequence encoding an origin of 
S. and R. H. Brlansky Phytopathology assembly and coat protein heterologous to said first virus, 
66:815-820) using anti-TMV virion antibody, rod shaped wherein said second virus RNA sequence is placed in a 
particles were consistently visualized in repeated experi- region of the RNA segment of said first virus to produce a 
These particles had several features charac- 40 hybrid RNA molecule, wherein said region is able to tolerate 
teristic of normal TMV virion particles, including an such sequence without disrupting RNA replication of or 
approximately 20 nm diameter and a central uranyl acetate- infection by said hybrid RNA molecule, and wherein said 
staining The particles were predominantly around hybrid molecule is constructed in vitro from said first 
110 nm in length, while the longest particles visualized in RNA segment and said second RNA sequences, or wherein 
the same way from protoplasts infected with TMV Cc virion 45 said hybrid molecule is descended from a nucleic acid 
RNA were around 310 nm in length. molecule constructed in vitro using recombinant DNA tech- 
Assuming a length of 6.4 kb for TMV RNA (Goelet et al. nology, 
(1982) Proc. Natl. Acad. Sci. 82:488-492), and a constant 11. A hybrid RNA molecule capable of infection of and 
ratio of RNA to particle length (Butler, supra), these results replication in a host cell, said hybrid RNA molecule com- 
imply that the major particle form from pB3tTMV infected 50 prising a BMV RNA3 sequence and an RNA sequence 
protoplasts contains an approximately 2.3 kb RNA, and that comprising an origin of assembly and encoding a coat 
the length of the P B ~ ~ V  RNAis approximately 2.2 kb. A protein derived from TMV, wherein the BMV coat protein 
Small fraction of shorter particles Was also Seen in the gene is deleted from or inactivated in said BMV RNA3 
P B ~ ~ V  derived preparations, and a larger fraction and a sequence and said TMV RNA sequence is substituted there- 
bnxder length distribution of particles shorter than 310 nm 55 for to produce a hybrid RNA molecule capable of expressing 
was also Seen from TMV Cc-infected preparations. Such the coat protein encoded by said TMV RNA sequence, and 
smaller particles may arise frombreakage of larger~articles wherein said hybrid molecule is constructed in vitro from 
or from encapsidation of subgenomic RNA's. said BMV RNA3 sequence and said TMV RNA sequence, 
The foregoing example is provided by way of illustration or wherein said hybrid molecule is descended from a nucleic 
and not by way of limitation of the invention. 60 acid molecule constructed in vitro using recombinant DNA 
We claim: technology. 
1. A hybrid RNA molecule capable of infection of and 
replication in a host cell, said hybrid RNA molecule com- * * * * *  

